Bandingkan Harga & Kinerja Aksara Global Development Tbk. (GAMA) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Aksara Global Development Tbk. dan UBC Medical Indonesia Tbk.: Aksara Global Development Tbk. diperdagangkan di Rp18 (kapitalisasi pasar 180,2 M), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 3,8× kapitalisasi pasar Aksara Global Development Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GAMA | LABS | |
|---|---|---|
Kapitalisasi Pasar | 180,2 M | 691,25 M |
Volume | — | 635,5 rb |
Lot | — | 6,36 rb |
Perputaran | — | 110,15 jt |
Harga Rata-rata | — | 173,33 |
Nilai Transaksi | — | 110,15 jt |
Harga Ekuilibrium Indikatif | — | 174 |
Volume Ekuilibrium Indikatif | — | 50 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Aksara Global Development Tbk.
PT Gading Development Tbk (formerly PT Artha Asia Pratama) was established based on notarial deed No. 45 dated December 18, 2003 of P. Sutrisno A. Tampubolon, S.H., M.Kn., notary in Jakarta.
Selengkapnya di halaman GAMA →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
